The average one-year price target for Accendra Health (NYSE: ACH) has been revised to $3.77 per share, a decrease of 69.55% from the previous estimate of $12.39 on August 26, 2022. The new target range provided by analysts spans from a low of $2.52 to a high of $5.25 per share, indicating a potential increase of 50.06% from the latest reported closing price of $2.52 per share.
Currently, there is one fund or institution reporting a position in Accendra Health, with no change over the last quarter. Institutional ownership is at 0K shares, while the portfolio weight of all funds dedicated to ACH has increased by 7.28%. The put/call ratio for ACH stands at 0.14, reflecting a bullish outlook.
